Cost-Effective Analysis (AEB) of Antiretroviral (ARV) Use of TLD and TLE in Outpatient HIV Patients
Downloads
Antiretroviral treatment is one of the biggest parts of the treatment for people infected with HIV. This study aims to determine the effectiveness of drugs and the cost efficiency of ARV combination drug therapy. The study used a non-experimental research design that was observational to determine the Cost Effectiveness Analysis of 2 combinations of ARVs, namely the combination of TLD (Tenofovir + Lamivudin + Dolutegraph), and the combination of TLE (Tenofovir + Lamivudin + Efavirenz). Data collection was carried out retrospectively from the medical record data of patients who started ARV treatment in the period 2021 to 2023. Total of 189 patients were actively treated as outpatients at VCT polyclinics and 64 who met the inclusion criteria were used as study subjects. The effectiveness of treatment uses the parameters of the Viral Load test results. Treatment is said to be effective if the Viral Load test result is <40 copies/mL. Based on the results of the Viral Load test, the TLD combination was more effective (75.9%) compared to the TLE combination (66.7%). Based on Cost Effective Analysis, the combination of TLD (Tenofovir + Lamivudin + Dolutegrafir) is better with an ACER value of IDR 39,871 compared to the combination of TLE (Tenofovir + Lamivudin + Efavirenz) with an ACER value of IDR 68,599.
Anggriani, Y., Generous Purba, F., & Manninda, R. (2020). Efavirenz in HIV/Aids Patients at Bekasi City Hospital (Cost Eff Ectiveness Analysis Of Combination Treatment Zidovudin, Lamivudin, Nevirapin And Combination Tenofovir, Lamivudin, Efavirenz HIV/Aids Patients In Bekasi Hospital). Indonesian Journal of Pharmaceutical Sciences, 18(2), 259–264.
Claudia, R. O., Rahmawati, D., & Fadraersada, J. (2018). Overview of Characteristics, Treatment Patterns and Compliance of HIV/AIDS Patients in Samarinda City. Proceedings Of Mulawarman Pharmaceuticals Conferences, 8, 104–110. Https://Doi.Org/10.25026/Mpc.V8i1.311
Clutter, D. S., Jordan, M. R., Bertagnolio, S., & Shafer, R. W. (2016). Hiv-1 Drug Resistance And Resistance Testing. Infection, Genetics And Evolution, 46, 292–307. Https://Doi.Org/10.1016/J.Meegid.2016.08.031
Cottrell, M. L., Hadzic, T., & Kashuba, A. D. M. (2013). Clinical Pharmacokinetic, Pharmacodynamic And Drug-Interaction Profile Of The Integrase Inhibitor Dolutegravir. Clinical Pharmacokinetics, 52(11), 981–994. Https://Doi.Org/10.1007/S40262-013-0093-2
Dewanti, Ersi, & Handayani. (2021). Determinants of Suppressed Viral Load in HIV and AIDS Patients. Student Journal of Bk An-Nur: Different, Meaningful, Noble, 7.
Jambi Provincial Health Office. (2022). Jambi Province Health Profile in 2022.
Dugdale, C. M., Ciaranello, A. L., Bekker, L.-G., Stern, M. E., Myer, L., Wood, R., Sax, P. E., Abrams, E. J., Freedberg, K. A., & Walensky, R. P. (2019). Risks And Benefits Of Dolutegravir- And Efavirenz-Based Strategies For South African Women With Hiv Of Child-Bearing Potential. Annals Of Internal Medicine, 170(9), 614. Https://Doi.Org/10.7326/M18-3358
Faridah, Nurul, Machlaurin, Afifah, & Subagijo, Prihwanto Budi. (2016). Analysis of the Cost Effectiveness of Antibiotic Use for Pediatric Sepsis Patients Inpatient at Dr. Soebandikabupaten Hospital, Jember in 2014. E-Journal of Health Literature, 4, 255–262.
Fitrianingsih, Ersa, C. B., Indriyani, D., & Wirdayanti. (2019). Description of the characteristics of HIV patients at the outpatient polyclinic of Raden Mattaher Jambi Hospital. Scientific Journal of Applied Sciences, University of Jambi, 3.
Hardjadipura, E. P., Hasan, D., & Winulyo, E. B. (2018). Cost Effectiveness Analysis of the Use of Combination Arv Drugs and Their Effect on the Quality of Life of HIV-Aids Patients at the Outpatient Polyclinic of Dr.H.Marzoeki Mahdi Hospital, Bogor. Farmagazine, V No. 3.
Ministry of Health of the Republic of Indonesia. (2013). Guidelines for the Implementation of Pharmacoeconomic Studies. Ministry of Health of the Republic of Indonesia, 1–96.
Ministry of Health of the Republic of Indonesia. (2019). Decree of the Minister of Health of the Republic of Indonesia on National Guidelines for HIV Governance Medical Services. Ministry of Health of the Republic of Indonesia.
Ministry of Health of the Republic of Indonesia. (2022a). Tri Monthly Report 1 2022 Development of HIV, AIDS and Sexually Transmitted Diseases (PIMS).
Ministry of Health of the Republic of Indonesia. (2022b). Regulation of the Minister of Health of the Republic of Indonesia concerning the Management of Human Immunodeficiency Virus, Acquaired Immunodeficiency Syndrome, and Sexually Transmitted Infections. Ministry of Health of the Republic of Indonesia. Www.Peraturan.Go.Id
Ministry of Health of the Republic of Indonesia. (2023). Performance Report for the First Semester of 2023.
Novrindo Sidjabat, F., Humairoh, D., & Riyaniarti Estri, M. (2019). Sex relationship with the incidence of Hbv and HCV infection in people with HIV/AIDS (ODHA). Biosphere Biology Scientific Magazine : A Scientific Journal, 36. Https://Doi.Org/10.20884/1.Mib.2019.36.1.706
Sidjabat, F. N., Setyawan, H., & Hadisaputro, S. (2016). Men Sex Men: Sexual Activity And How Do They Get Started? (Reproductive Health Study on Lsl Community in Semarang City) Men Who Have Sex With Men: Sexual Activity And How They Start? (Case Study Of Reproduction Health On Msm Community In Semarang City).
Umam, H., Dewi, Y. I., Elita, V., Program, M., Nursing, S. I., Riau, U., & Program, D. (2015). Identification of characteristics of high-risk people of HIV and AIDS about the Voluntary Counseling and Testing (VCT) service program. In Jom (Vol. 2, Issue 1).
World Health Organization. (2019). Policy Brief: Update Of Recommendations On First And Second-Line Antiretroviral Regimen. Http://Apps.Who.Int/Bookorders.
Copyright (c) 2025 Meidi Kurniadi Rafindra, Medi Andriani, Rasmala Dewi
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
